Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Alberghini

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cancer|January 16, 2007
Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same yearsGaetano Bacci, Alba Balladelli, Cristiana Forni, et al.
Virchows Archiv : an International Journal of Pathology|December 6, 2012
Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroupJakob K Anninga, Piero Picci, Marta Fiocco, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 12, 2009
Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institutionGaetano Bacci, Stefano Boriani, Alba Balladelli, et al.
Histopathology|July 27, 2010
Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastasesLaura Pazzaglia, Amalia Conti, Antonella Chiechi, et al.
Skeletal Radiology|August 12, 2009
Selective arterial embolization of 36 aneurysmal bone cysts of the skeleton with N-2-butyl cyanoacrylateGiuseppe Rossi, Eugenio Rimondi, Tommaso Bartalena, et al.
Annals of Surgical Oncology|October 23, 2009
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centersSilvia Stacchiotti, Paolo Giovanni Casali, Salvatore Lo Vullo, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Palliative therapy for osteosarcomaCostantino Errani, Alessandra Longhi, Giuseppe Rossi, et al.
Clinical Sarcoma Research|May 17, 2012
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberansEmanuela Palmerini, Marco Gambarotti, Eric L Staals, et al.
Tumori|June 25, 2010
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional studyStefano Ferrari, Emanuela Palmerini, Marco Alberghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cancer|January 16, 2007
Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same yearsGaetano Bacci, Alba Balladelli, Cristiana Forni, et al.
Virchows Archiv : an International Journal of Pathology|December 6, 2012
Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroupJakob K Anninga, Piero Picci, Marta Fiocco, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 12, 2009
Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institutionGaetano Bacci, Stefano Boriani, Alba Balladelli, et al.
Histopathology|July 27, 2010
Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastasesLaura Pazzaglia, Amalia Conti, Antonella Chiechi, et al.
Skeletal Radiology|August 12, 2009
Selective arterial embolization of 36 aneurysmal bone cysts of the skeleton with N-2-butyl cyanoacrylateGiuseppe Rossi, Eugenio Rimondi, Tommaso Bartalena, et al.
Annals of Surgical Oncology|October 23, 2009
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centersSilvia Stacchiotti, Paolo Giovanni Casali, Salvatore Lo Vullo, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Palliative therapy for osteosarcomaCostantino Errani, Alessandra Longhi, Giuseppe Rossi, et al.
Clinical Sarcoma Research|May 17, 2012
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberansEmanuela Palmerini, Marco Gambarotti, Eric L Staals, et al.
Tumori|June 25, 2010
Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional studyStefano Ferrari, Emanuela Palmerini, Marco Alberghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
Pageof 7